UPLOAD Filing
KIORA PHARMACEUTICALS INC
Date: Sept. 16, 2025 · CIK: 0001372514 · Accession: 0000000000-25-010034
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290263
Letter
Re: Kiora Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed September 15, 2025 File No. 333-290263 Dear Brian M. Strem:
September 16, 2025
Brian M. Strem Chief Executive Officer Kiora Pharmaceuticals, Inc. 169 Saxony Rd. Suite 212 Encinitas, CA 92024
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Robert A. Petitt, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 16, 2025 Brian M. Strem Chief Executive Officer Kiora Pharmaceuticals, Inc. 169 Saxony Rd. Suite 212 Encinitas, CA 92024 Re: Kiora Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed September 15, 2025 File No. 333-290263 Dear Brian M. Strem: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Robert A. Petitt, Esq. </TEXT> </DOCUMENT>